Templeman Blaine 4
4 · ADURO BIOTECH, INC. · Filed Sep 14, 2017
Insider Transaction Report
Form 4
Templeman Blaine
Executive VP, General Counsel
Transactions
- Sale
Common Stock
2017-09-13$10.99/sh−3,557$39,076→ 61,718 total - Award
Common Stock
2017-09-12+27,975→ 65,275 total
Footnotes (2)
- [F1]Represents grant of restricted stock units payable in common stock that vest in four equal annual installments from the grant date of September 12, 2017.
- [F2]The shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.